Covid-19 vaccine: Bangladesh has signed an agreement with India to buy 30 million doses on Thursday. British drug manufacturer AstraZeneca’s developed vaccine is considered a potential candidate against the corona virus. Bangladesh Health Minister Zahid Malik told reporters that the agreement was signed in Dhaka.
Bangladesh will buy 30 million doses of Kovid vaccine from India
He said, “Whenever the vaccine is ready, the Serum Institute of India will give us 30 million doses in the first phase.” He also informed that a dose of five million vaccines would be purchased every month from BangiMesh drug maker Beximo Pharmaceuticals. Malik informed that 15 million people will be vaccinated and two doses of vaccine will be required for each person. Serum Institute, the world’s leading vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and Gavai to prepare and supply more than one billion doses of the Kovid-19 vaccine globally.
Oxford vaccine is being considered as a strong contender
AstraZeneca has tied up with many companies in the world to manufacture and supply vaccines. Officials said that the government of Bangladesh is in talks with the World Bank and Asian Development Bank, including developed partners, to secure funds for the vaccine. Meanwhile, there is uncertainty over the final phase of human trials of the potential Kovid-19 vaccine for Synovac Biotech in Bangladesh as the government has stepped aside from meeting the Chinese company’s co-funding demand. In the field of vaccine preparation, the Indian vaccine manufacturer Serum is considered to be prominent in the world.
IPL 2020: RCB coach Simon Katich admitted defeat, told where the team lacked
Video: Kareena Kapoor Khan’s video angry on the thinking of society, viral on social media, angrily said big thing